Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) Shares Outstanding (Diluted Average) (2016 - 2025)

Medicure has reported Shares Outstanding (Diluted Average) over the past 14 years, most recently at $57.74 for Q2 2025.

  • For Q2 2025, Shares Outstanding (Diluted Average) rose 163.23% year-over-year to $57.74; the TTM value through Jun 2025 reached $57.74, up 163.23%, while the annual FY2024 figure was $35.79, 20.73% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q2 2025 was $57.74 at Medicure, up from $48.78 in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $95.77 in Q4 2022 and troughed at $7.33 in Q3 2024.
  • A 5-year average of $42.47 and a median of $36.54 in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 89.06% in 2021 and later soared 163.23% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $70.0 in 2021, then surged by 36.82% to $95.77 in 2022, then crashed by 69.32% to $29.38 in 2023, then rose by 21.82% to $35.79 in 2024, then skyrocketed by 61.31% to $57.74 in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for MCUJF at $57.74 in Q2 2025, $48.78 in Q1 2025, and $35.79 in Q4 2024.